Small Peptide-Doxorubicin Co-Assembly for Synergistic Cancer Therapy

Design of elaborated nanomaterials to improve the therapeutic efficacy and mitigate the side effects of chemotherapeutic anticancer drugs, such as Doxorubicin (Dox), is significant for cancer treatment. Here, we describe a co-assembled strategy, where amphiphile short peptides are co-assembled with...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuangfei, Chen, Xianglan, Chen, Huirong, Peng, Jiaofeng, Yang, Xuewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036863/
https://www.ncbi.nlm.nih.gov/pubmed/31979298
http://dx.doi.org/10.3390/molecules25030484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036863/
https://www.ncbi.nlm.nih.gov/pubmed/31979298
http://dx.doi.org/10.3390/molecules25030484

Ejemplares similares